State Board of Administration of Florida Retirement System’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-29,583
| Closed | -$21.6K | – | 2108 |
|
|
2025
Q2 | $21.6K | Hold |
29,583
| – | – | ﹤0.01% | 2146 |
|
|
2025
Q1 | $23.9K | Hold |
29,583
| – | – | ﹤0.01% | 2148 |
|
|
2024
Q4 | $40.8K | Hold |
29,583
| – | – | ﹤0.01% | 2177 |
|
|
2024
Q3 | $30.8K | Hold |
29,583
| – | – | ﹤0.01% | 2217 |
|
|
2024
Q2 | $51.2K | Buy |
29,583
+90
| +0.3% | +$181 | ﹤0.01% | 2177 |
|
|
2024
Q1 | $202K | Sell |
29,493
-90
| -0.3% | -$221 | ﹤0.01% | 1925 |
|
|
2023
Q4 | $98.5K | Hold |
29,583
| – | – | ﹤0.01% | 2246 |
|
|
2023
Q3 | $111K | Buy |
29,583
+90
| +0.3% | +$416 | ﹤0.01% | 2203 |
|
|
2023
Q2 | $126K | Hold |
29,493
| – | – | ﹤0.01% | 2228 |
|
|
2023
Q1 | $202K | Hold |
29,493
| – | – | ﹤0.01% | 2004 |
|
|
2022
Q4 | $234K | Sell |
29,493
-1,480
| -5% | -$11.4K | ﹤0.01% | 1979 |
|
|
2022
Q3 | $298K | Hold |
30,973
| – | – | ﹤0.01% | 1863 |
|
|
2022
Q2 | $224K | Buy |
30,973
+10
| +0% | +$87 | ﹤0.01% | 2063 |
|
|
2022
Q1 | $400K | Hold |
30,963
| – | – | ﹤0.01% | 1884 |
|
|
2021
Q4 | $494K | Hold |
30,963
| – | – | ﹤0.01% | 1823 |
|
|
2021
Q3 | $498K | Hold |
30,963
| – | – | ﹤0.01% | 1827 |
|
|
2021
Q2 | $428K | Buy |
30,963
+5,478
| +21% | +$77.6K | ﹤0.01% | 1953 |
|
|
2021
Q1 | $372K | Hold |
25,485
| – | – | ﹤0.01% | 1958 |
|
|
2020
Q4 | $443K | Hold |
25,485
| – | – | ﹤0.01% | 1834 |
|
|
2020
Q3 | $467K | Hold |
25,485
| – | – | ﹤0.01% | 1675 |
|
|
2020
Q2 | $455K | Hold |
25,485
| – | – | ﹤0.01% | 1671 |
|
|
2020
Q1 | $413K | Hold |
25,485
| – | – | ﹤0.01% | 1595 |
|
|
2019
Q4 | $459K | Hold |
25,485
| – | – | ﹤0.01% | 1745 |
|
|
2019
Q3 | $516K | Hold |
25,485
| – | – | ﹤0.01% | 1677 |
|
|
2019
Q2 | $563K | Buy |
25,485
+3,390
| +15% | +$58.9K | ﹤0.01% | 1667 |
|
|
2019
Q1 | $301K | Hold |
22,095
| – | – | ﹤0.01% | 1982 |
|
|
2018
Q4 | $200K | Buy |
22,095
+3,122
| +16% | +$36.1K | ﹤0.01% | 2126 |
|
|
2018
Q3 | $313K | Buy |
18,973
+420
| +2% | +$7.45K | ﹤0.01% | 2066 |
|
|
2018
Q2 | $260K | Buy |
18,553
+790
| +4% | +$11.3K | ﹤0.01% | 2169 |
|
|
2018
Q1 | $196K | Hold |
17,763
| – | – | ﹤0.01% | 2238 |
|
|
2017
Q4 | $156K | Hold |
17,763
| – | – | ﹤0.01% | 2310 |
|
|
2017
Q3 | $237K | Hold |
17,763
| – | – | ﹤0.01% | 2214 |
|
|
2017
Q2 | $255K | Buy |
17,763
+3,174
| +22% | +$61.1K | ﹤0.01% | 2169 |
|
|
2017
Q1 | $309K | Hold |
14,589
| – | – | ﹤0.01% | 2058 |
|
|
2016
Q4 | $411K | Buy |
14,589
+130
| +0.9% | +$3.64K | ﹤0.01% | 1962 |
|
|
2016
Q3 | $387K | Buy |
14,459
+180
| +1% | +$4.91K | ﹤0.01% | 1966 |
|
|
2016
Q2 | $241K | Buy |
+14,279
| New | +$268K | ﹤0.01% | 2134 |
|
Other funds holding CHRS
TCM
KKRC
CM
CWG
PAM
State Board of Administration of Florida Retirement System's CHRS Position: Q3 2025 in Review
State Board of Administration of Florida Retirement System sold out of Coherus Oncology (CHRS) in Q3 2025, closing a stake of 29,583 shares — an estimated $21.6K sold.
State Board of Administration of Florida Retirement System first reported a position in CHRS in Q2 2016 and held it in 37 quarters. The position peaked at $563K in Q2 2019. 114 funds tracked by Wall St. Rank hold CHRS as of Q3 2025.
- State Board of Administration of Florida Retirement System reported no remaining Coherus Oncology position as of Q3 2025 after selling out during the quarter.
- State Board of Administration of Florida Retirement System sold 29,583 Coherus Oncology shares in Q3 2025, an estimated $21.6K.
- State Board of Administration of Florida Retirement System first reported a position in Coherus Oncology in Q2 2016 and held it in 37 quarters.
- State Board of Administration of Florida Retirement System's Coherus Oncology position peaked at $563K in Q2 2019.
- 114 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2025.
Based on State Board of Administration of Florida Retirement System's 13F filing for Q3 2025, filed 14 Nov 2025.